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Saphenous vein homograft containing a valve as a right
ventricle–pulmonary artery conduit in the modified Norwood operation
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Hiroo Takayama, MD, Noboru Motomura, MD, Tomohiro Murakawa, MD, and Minoru Ono, MD, Tokyo, Japan
We report a case of hypoplastic left heart syndrometreated by means of the modified Norwood oper-ation with a saphenous vein homograft containinga valve as an extracardiac right ventricle–pulmo-
nary artery conduit (RV-PA conduit).
Clinical Summary
The modified Norwood operation was performed to treat hypo-
plastic left heart syndrome in a 7-day-old boy weighing 2.7 kg.
Preoperative echocardiography demonstrated aortic stenosis (aor-
tic valve diameter, 2.0 mm) and mitral stenosis (mitral valve
diameter, 4.5 mm) and a large secundum-type atrial septal defect,
hypoplastic aortic arch, aortic coarctation, and mild-to-moderate
tricuspid regurgitation. Ventilator support with 19% of inspired
oxygen fraction and alprostadil (prostaglandin E1) administration
were started on postnatal day 2.
After median sternotomy, a 3.0-mm polytetrafluoroethylene
(PTFE) graft was anastomosed to the right innominate artery as a
perfusion line. Cardiopulmonary bypass was instituted by means
of bicaval drainage, and another perfusion cannula was inserted
into the descending aorta for the lower body perfusion.1 The right
and left PAs were choked up, and a venting cannula was inserted.
When the rectal temperature reached 32°C, a vascular clamp was
placed on the descending aorta, and the ductus arteriosus was
ligated and divided. The ductal tissue in the isthmus was removed,
and the main PA was divided at the bifurcation level. The systemic
outflow tract was reconstructed without synthetic material, partly
during isolated cerebral and myocardial perfusion and partly with
the heart arrested.2 The right atrium was opened, and a wide
interatrial communication was confirmed. An 8-mm vertical ven-
triculotomy was made on the right ventricular outflow tract, and a
small amount of the muscle was resected. A saphenous vein
homograft containing a valve with an external diameter of 4 mm
(supplied by the University of Tokyo Tissue Bank, Tokyo, Japan)
was thawed, and valve competence was checked. An obliquely cut
end was anastomosed to the ventriculotomy, the right atriotomy
was closed, and the coronary arteries were reperfused. During
rewarming, the distal end of the homograft was trimmed and
connected to the bifurcation of the PA (Figure 1). The pump
termination was smooth, with excellent hemodymanics. The pul-
monary flow/systemic flow ratio at the operating room was calcu-
lated as 0.99: oxygen saturation of the arterial blood was 69%,
with a 21% inspired oxygen fraction; saturation of the blood taken
from the superior vena cava was 40.5%; and the pulmonary venous
blood saturation was 99%. A CV-0 PTFE suture was left in place
around the homograft for possible adjustment of the conduit. The
central venous pressure was 5 mm Hg, and the systemic systolic
and diastolic blood pressures were 75 mm Hg and 38 mm Hg,
respectively. The sternum was split with a short segment of 7-mm
endotracheal tube stent. The pump time was 201 minutes, and the
myocardial ischemic time was 46 minutes. The procedure lasted 6
hours and 5 minutes. The patient’s metabolic acidosis and hyper-
lactatenemia improved within 24 hours postoperatively. Perioper-
ative care, including pulmonary flow/systemic flow adjustment by
means of titration of sodium nitroprusside, conformed to that
described in a published article.3
The postoperative course was stable, with satisfactory renal and
liver function, and no neurologic deficits were detected. Echocar-
diography demonstrated trivial regurgitant signals in the ho-
mograft (Figure 2), and the patient is now waiting for the second-
stage bidirectional Glenn shunt.
Discussion
Use of an RV-PA conduit as a source of the pulmonary flow
instead of a PTFE Blalock-Taussig shunt has been reported in the
Norwood operation.2,4 Imoto and coworkers2 reported higher
postopertative systemic diastolic pressure in patients with an
RV-PA nonvalved PTFE conduit and suggested that the higher
systemic diastolic pressure leads to better coronary blood flow and
results in stable circulation. However, the drawbacks of this tech-
nique (ie, the possible deleterious effects of right ventriculotomy
and pulmonary regurgitation through the conduit) need to be
carefully monitored. In our experience moderate regurgitant sig-
nals were detected during the acute postoperative phase. In the
present case the valve in the saphenous vein homograft almost
completely eliminated the pulmonary regurgitation, and the hemo-
dynamics were better than those in the case with the nonvalved
conduit.
Chronic rejection and long-term function of the homograft are
concerns. Good long-term function and less thrombogenicity of
saphenous vein homografts as a Blalock-Taussig shunt material
have been reported.5,6 Close observation of valve function is
mandatory. If any signs of stenosis are detected, an additional
Blalock-Taussig shunt or early second-stage bidirectional Glenn
shunt are options.
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In conclusion, use of a saphenous vein homograft containing a
competent valve as an RV-PA conduit in the modified Norwood
operation eliminates pulmonary regurgitation and leads to superior
postoperative hemodynamics and an improved outcome.
We thank Ms Noriko Yoneda and Ms Sakiko Shibusawa for
their help in shipping and thawing of the homograft.
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Figure 1. Proximal anastomosis of the saphenous vein homograft
(G). The valve is located 6 mm distal to the proximal anastomosis.
Figure 2. Postoperative echocardiography with Doppler flow map-
ping in the homograft demonstrated trivial regurgitant signals (R).
The motion of the valve (arrow) could be observed.
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